Clinics on Cambodian-Thai border aim to prevent spread of drug-resistant malaria

NewsGuard 100/100 Score

BBC News examines "a worrying drop in the effectiveness of the artemisinin-based drugs" against malaria along the Cambodian-Thai border, and how clinics are attempting to combat the trend by offering monetary incentives to patients to complete treatment regimens. "Thanks to the efforts of health workers ... , and the widespread availability of treatment, malaria still only kills a handful of people in Thailand each year," according to the BBC. "The focus now is on trying to monitor and contain artemisinin drug resistance into a few hotspots, prolonging the drug's effective lifespan globally until alternative treatments are available," the news service writes, adding, "Africa's hopes of maintaining its progress rests firmly on South East Asia's efforts." Fatoumata Nafo-Traore, executive director of Roll Back Malaria and the former health minister of Mali, said if drug-resistant malaria reached Africa, it would be a "massive crisis" because there is not an alternative drug to the usually highly effective artemisinin-based drugs, according to BBC (Fisher, 11/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel malaria test by Rice University offers rapid diagnosis and treatment